Ultragenyx
Price & Volume
Stats
See moreOpen | $23.07 |
Previous Close | $23.04 |
Day Range | $22.80-$23.46 |
52W Range | $18.41-$43.22 |
Market Cap | $2.2B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $673M |
Revenue Growth (YoY) | 25.9% |
Gross Profit (12 Mos) | -$186M |
Diluted EPS | -$5.83 |
News
See moreYahoo Finance • 2 days ago
Ultragenyx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Ultragenyx Pharmaceutical Inc. - RARE
Yahoo Finance • 2 days ago
Bronstein, Gewirtz & Grossman LLC Urges Ultragenyx Pharmaceutical Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Yahoo Finance • 3 days ago
Ultragenyx Pharmaceutical Inc. (RARE): A Bull Case Theory
Yahoo Finance • 4 days ago
Ultragenyx to Participate at Investor Conferences in March
About
CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
CFO | Mr. Howard Horn |
Address | 60 Leveroni Court, Novato, CA, United States, 94949 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,371 |
